MAZE Maze Therapeutics, Inc.

NASDAQ
$24.60

Maze Therapeutics, Inc. (MAZE) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with MAZE's own trailing one-year pace, with 87% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
7
90 transactions
Purchases
$0
0 shares
Sales
$21.7M
637,972 shares
Net activity
-$21.7M
purchases less sales

How much of that selling was preplanned? 87% planned / 13% discretionary

10b5-1 plan sales $18.9M 71 transactions · 544,455 shares
Discretionary sales $2.8M 19 transactions · 93,517 shares

Largest single sale: $2.7M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Bernstein Harold President, R&D & CMO Sell 10b5-1 9,705 $26.22 $254.5K None left
Coloma Jason V 2 fills Chief Executive Officer Sell 11,411 $26.01 $296.8K 27,491 −29.3% of holding
Bernstein Harold 2 fills President, R&D & CMO Sell 5,189 $26.01 $135.0K 9,764 −34.7% of holding
Dandekar Atul 2 fills CSBO Sell 3,243 $26.01 $84.4K 32,352 −9.1% of holding
Courtney Phillips 2 fills GC and Corp. Secretary Sell 2,012 $26.01 $52.3K 7,029 −22.3% of holding
Coloma Jason V 2 fills Chief Executive Officer Sell 11,227 $26.47 $297.1K 40,148 −21.9% of holding
Bernstein Harold 2 fills President, R&D & CMO Sell 5,106 $26.47 $135.1K 15,519 −24.8% of holding
Dandekar Atul 2 fills CSBO Sell 3,191 $26.47 $84.5K 35,950 −8.2% of holding
Courtney Phillips 2 fills GC and Corp. Secretary Sell 1,981 $26.47 $52.4K 9,262 −17.6% of holding
Bernstein Harold President, R&D & CMO Sell 10b5-1 16,141 $26.36 $425.5K None left
Dandekar Atul CSBO Sell 10b5-1 7,500 $27.58 $206.8K 26,250 −22.2% of holding
Bernstein Harold President, R&D & CMO Sell 10b5-1 16,142 $27.61 $445.6K None left
Coloma Jason V 4 fills Chief Executive Officer Sell 10b5-1 34,501 $26.73 $922.3K 256,867 −11.8% of holding
Dandekar Atul 2 fills CSBO Sell 10b5-1 7,500 $27.34 $205.0K 26,650 −22% of holding
Coloma Jason V 3 fills Chief Executive Officer Sell 10b5-1 34,501 $29.98 $1.0M 288,768 −10.7% of holding
Bernstein Harold 2 fills President, R&D & CMO Sell 10b5-1 14,609 $29.90 $436.9K 1,200 −92.4% of holding
Dandekar Atul CSBO Sell 10b5-1 7,500 $28.02 $210.2K 26,250 −22.2% of holding
Coloma Jason V Chief Executive Officer Sell 10b5-1 23,865 $26.05 $621.7K 319,079 −7% of holding
Coloma Jason V 2 fills Chief Executive Officer Sell 10b5-1 3,993 $26.00 $103.8K 342,944 −1.2% of holding
Bernstein Harold 2 fills President, R&D & CMO Sell 10b5-1 14,853 $25.66 $381.1K 1,600 −90.3% of holding
Coloma Jason V 2 fills Chief Executive Officer Sell 10b5-1 6,643 $26.20 $174.0K 344,897 −1.9% of holding
Dandekar Atul CSBO Sell 10b5-1 7,500 $26.34 $197.6K 24,808 −23.2% of holding
Coloma Jason V Chief Executive Officer Sell 10b5-1 25,582 $26.02 $665.5K 350,987 −6.8% of holding
Coloma Jason V 2 fills Chief Executive Officer Sell 10b5-1 6,982 $26.00 $181.5K 376,569 −1.8% of holding
Coloma Jason V 2 fills Chief Executive Officer Sell 10b5-1 1,938 $26.00 $50.4K 381,073 −0.5% of holding
Bernstein Harold President, R&D & CMO Sell 10b5-1 15,000 $26.22 $393.4K None left
Dandekar Atul CSBO Sell 10b5-1 7,500 $25.37 $190.3K 10,503 −41.7% of holding
Bernstein Harold 3 fills President, R&D & CMO Sell 10b5-1 15,000 $29.46 $441.9K 3,648 −80.4% of holding
Bachrodt Amy 2 fills SVP, Finance Sell 10b5-1 2,500 $29.44 $73.6K 13,265 −15.9% of holding
Dandekar Atul 2 fills CSBO Sell 10b5-1 7,500 $29.34 $220.0K 11,293 −39.9% of holding
Bernstein Harold 3 fills President, R&D & CMO Sell 10b5-1 15,000 $49.10 $736.4K 8,839 −62.9% of holding
Bernstein Harold 2 fills President, R&D & CMO Sell 10b5-1 30,000 $50.45 $1.5M 348 −98.9% of holding
Bachrodt Amy 2 fills SVP, Finance Sell 10b5-1 5,000 $45.20 $226.0K 16,665 −23.1% of holding
Dandekar Atul 2 fills CSBO Sell 10b5-1 7,500 $45.43 $340.7K 14,264 −34.5% of holding
Bernstein Harold 4 fills President, R&D & CMO Sell 10b5-1 15,000 $46.02 $690.3K 14,400 −51% of holding
Bachrodt Amy 3 fills SVP, Finance Sell 10b5-1 5,000 $46.04 $230.2K 17,765 −22% of holding
Dandekar Atul 3 fills CSBO Sell 10b5-1 7,500 $44.27 $332.0K 16,803 −30.9% of holding
Bachrodt Amy SVP, Finance Sell 10b5-1 5,000 $45.52 $227.6K 12,965 −27.8% of holding
Sohn Catherine A. Director Sell 26,920 $39.11 $1.1M None left
Bernstein Harold President, R&D & CMO Sell 10b5-1 25,156 $40.20 $1.0M None left
Sohn Catherine A. Director Sell 2,493 $38.62 $96.3K None left
Bernstein Harold President, R&D & CMO Sell 10b5-1 412 $40.00 $16.5K None left
Bachrodt Amy 2 fills SVP, Finance Sell 10b5-1 5,000 $39.15 $195.8K 15,560 −24.3% of holding
Bernstein Harold President, R&D & CMO Sell 10b5-1 4,432 $40.43 $179.2K None left
Bachrodt Amy SVP, Finance Sell 10b5-1 5,000 $40.08 $200.4K 12,965 −27.8% of holding
Dandekar Atul CSBO Sell 10b5-1 100 $40.36 $4.0K 10,503 −0.9% of holding
Dandekar Atul 2 fills CSBO Sell 10b5-1 72,400 $40.56 $2.9M 16,538 −81.4% of holding
Bernstein Harold 2 fills President, R&D & CMO Sell 10b5-1 45,000 $40.56 $1.8M 17,200 −72.3% of holding
Bachrodt Amy 2 fills SVP, Finance Sell 10b5-1 10,000 $40.58 $405.8K 13,565 −42.4% of holding
SCHELLER RICHARD H Director Sell 20,744 $22.37 $464.0K None left

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.